Pharmaceutical News of the Week | CPhI.CN - Performance

(July.27th-31th)

24. Chipscreen released its 2020 H1 performance report on July 27, according to which, its operating income reached RMB110 million, growing by 35% year on year, the net profit attributable to shareholders of the listed company reached RMB28.71 million, growing by 63.97% year on year, and basic earnings per share reached RMB0.07, growing by 44.03% year on year.

Read More:

Pharmaceutical News of the Week | CPhI.CN - Policies

About  the Author:    

Caicai, a Master of Pharmacy from Shanghai Jiaotong University, used to work in the Institute of Science and Technical Information. Currently as a practitioner in the drug surveillance system, she is good at interpreting industry regulations, pharmaceutical research developments, etc.

-----------------------------------------------------------------------
Editor's Note:

To become a freelance writer of PharmaSources.com,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@imsinoexpo.com.